Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.

ANP Insider Trading (Antisense Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$57,582.16
Insider Selling (Last 12 Months): A$0.00

Antisense Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Antisense Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Antisense Therapeutics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for ANP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Investor Alert: Argentina Loaded With "White Gold" Opportunity
Experts expect the global lithium market to grow by 500% due to the explosion of electric vehicles and green energy. And one small-cap company just snagged a large lithium deposit in a renowned South American location.
Read about this once-in-a-lifetime opportunity

Antisense Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/28/2022Mark DiamondInsiderBuy244,687A$0.11A$26,915.57
12/22/2021Mark DiamondInsiderIssued470,549A$0.24A$112,931.76
11/8/2021Charmaine GittlesonInsiderBuy133,333A$0.23A$30,666.59
12/3/2020Robert MosesInsiderIssued90,201A$0.10A$9,020.10
12/23/2019Graham MitchellInsiderIssued7,000,000A$0.09A$609,000.00
12/20/2019Robert MosesInsiderBuy100,000A$0.09A$8,800.00
12/18/2019Graham MitchellInsiderExercise48,036A$0.08A$3,842.88
12/16/2019Robert MosesInsiderBuy618,888A$0.08A$49,511.04
12/3/2019Robert MosesInsiderBuy800,000A$0.08A$64,000.00
See Full Table
Crypto Millionaire: “Pay Attention to May 20th”
Charlie Shrem is like the “Godfather of Cryptocurrencies”. He discovered Bitcoin when it was trading for $5. Ethereum at $109. Binance at just $6. Cardano for 5 CENTS.

Today, he’s sharing the details of a $0.21 CENT crypto with Top 5 Potential… as well as his BIG prediction for May 20th.
Get the details NOW.

SEC Filings (Institutional Ownership Changes) for Antisense Therapeutics (ASX:ANP)

Antisense Therapeutics Limited, a biopharmaceutical company, engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase II clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia.
Read More on Antisense Therapeutics

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


1,318,309 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Antisense Therapeutics?

Antisense Therapeutics' top insider shareholders include:
  1. Charmaine Gittleson (Insider)
  2. Mark Diamond (Insider)
  3. Robert Moses (Insider)
Learn More about top insider investors at Antisense Therapeutics.
This Stock Under $2 Could Go to $20 (And STILL Be a SCREAMING BUY)
Analysts predict earnings will soar more than 320% this year...Possibly as much as 500%!

Discover the last opportunity that could still rocket skyward in THIS market.

Click Here to Discover Details on the Shocking Less Than $2 Stock.